The safety and analgesic efficacy of intranasal ketorolac in patients with postoperative pain

Anesthesia and Analgesia

Volumn 107, Issue 6, 2008, Pages 2025-2031

  Moodie, John E ^a   Brown, Colin R ^a   Bisley, Eileen J ^a   Weber, Hans U ^b   Bynum, Lincoln ^c  

^a WAIKATO HOSPITAL   (New Zealand)

^b ICON Clinical Research ^*

^c ICON CLINICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ANALGESIC AGENT; FENTANYL; KETOROLAC; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; REMIFENTANIL; TRAMADOL;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FEVER; FLUID RETENTION; HEMATEMESIS; HUMAN; INDUCED HYPOTENSION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MAXIMUM PLASMA CONCENTRATION; NAUSEA; NOCICEPTION; NOSE IRRITATION; OLIGURIA; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE; VOMITING; INTRANASAL DRUG ADMINISTRATION; MIDDLE AGED;

ADMINISTRATION, INTRANASAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KETOROLAC; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE;

EID: 58149295885     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318188b736     Document Type: Article

References (24)

1. Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997;53:139-88
2. Sankar C, Mishra B. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm 2003;53:101-10
3. Quadir M, Zia H, Needham TE. Development and evaluation of nasal formulations of ketorolac. Drug Deliv 2000;7:223-9
4. Santus G, Rivolta R, Bottoni G, Testa B, Canali S, Peano S. Nasal formulations of ketorolac tromethamine: technological evaluation-bioavailability and tolerability in rabbits. Farmaco 1993;48:1709-23
5. McAleer SD, Majid O, Venables E, Polack T, Sheikh MS. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers. J Clin Pharmacol 2007;47:13-8
6. Jung D, Mroszczak E, Bynum L. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular, and oral administration. Eur J Clin Pharmacol 1988;35:423-5
7. Toradol® IM/IV/Oral Package Insert. Nutley, NJ: Roche Laboratories, Inc.
8. Held BI, Michels A, Blanco J, Ascher-Walsh C. The effect of ketorolac on febrile episodes in patients after abdominal myomectomy. Am J Obstet Gynecol 2002;187:1450-5
9. Ready LB, Brown CR, Stahlgren LH, Egan KJ, Ross B, Wild L, Moodie JE, Jones SF, Tommeraasen M, Trierwieler M. Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain. Anesthesiology 1994;80:1277- 86
10. Eberson CP, Pacicca DM, Ehrlich MG. The role of ketorolac in decreasing length of stay and narcotic complications in the postoperative pediatric orthopaedic patient. J Pediatr Orthop 1999;19:688-92
11. Reuben SS, Connelly NR, Lurie S, Klatt M, Gibson CS. Doseresponse of ketorolac as an adjunct to patient-controlled analgesia morphine in patients after spinal fusion surgery. Anesth Analg 1998;87:98-102
12. Picard P, Bazin JE, Conio N, Ruiz F, Schoeffler P. Ketorolac potentiates morphine in postoperative patient-controlled analgesia. Pain 1997;73:401-6
13. Reuben SS, Connelly NR, Steinberg R. Ketorolac as an adjunct to patient-controlled morphine in postoperative spine surgery patients. Reg Anesth 1997;22:343-6
14. Sevarino FB, Sinatra RS, Paige D, Ning T, Brull S, Silverman DG. The efficacy of intramuscular ketorolac in combination with intravenous PCA morphine for postoperative pain relief. J Clin Anesth 1992;4:285-8
15. Cataldo PA, Senagore AJ, Kilbride MJ. Ketorolac and patientcontrolled analgesia in the treatment of postoperative pain. Surg Gynecol Obstet 1993;176:435-8
16. Grass JA, Sakima NT, Valley M, Fischer K, Jackson C, Walsh P, Bourke DL. Assessment of ketorolac as an adjuvant to fentanyl patient-controlled epidural analgesia after radical retropubic prostatectomy. Anesthesiology 1993;78:642-8
17. DeAndrade JR, Maslanka M, Reines HD, Howe D, Rasmussen GL, Cardea J, Brown J, Bynum L, Shefrin A, Chang YL, Maneatis T. Ketorolac versus meperidine for pain relief after orthopedic surgery. Clin Orthop 1996;325:301-12
18. Perttunen K, Nilsson E, Kalso E. I.v. diclofenac and ketorolac for pain after thoracoscopic surgery. Br J Anaesth 1999;82:221-7
19. O'Hara DA, Fanciullo G, Hubbard L, Maneatis T, Seuffert P, Bynum L, Shefrin A. Evaluation of the safety and efficacy of ketorolac versus morphine by patient-controlled analgesia for postoperative pain. Pharmacotherapy 1997;17:891-9
20. Carney DE, Nicolette LA, Ratner MH, Minerd A, Baesl TJ. Ketorolac reduces postoperative narcotic requirements. J Pediatr Surg 2001;36:76-9
21. Lowder JL, Shackelford DP, Holbert D, Beste TM. A randomized, controlled trial to compare ketorolac tromethamine versus placebo after cesarean section to reduce pain and narcotic usage. Am J Obstet Gynecol 2003;189:1559-62
22. Tong D, Chung F. Postoperative pain control in ambulatory surgery. Surg Clin North Am 1999;79:401-30
23. White PF. The changing role of nonopioid surgical techniques in the management of postoperative pain. Anesth Analg 2005;101(5 Suppl):S5-22
24. Joshi GP, White PF. Management of acute and postoperative pain. Curr Opin Anaesthiol 2001;14:417-21